SCHEMBL23488609

SCHEMBL23488609

COc1cc(C(=O)OC[C@H]2OC(C)[C@H](O)[C@@H](O)[C@@H]2O)ccc1OC(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.48
TDP1 Q9NUW8 3/20 0.48
KMT2A Q03164 5/20 0.47
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 2/20 0.45
SELP P16109 2/20 0.45
SELL P14151 1/20 0.45
TYMP P19971 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488434 0.91 XDH (0.49) XDHTDP1KMT2AMEN1CYP3A4
SCHEMBL23488261 0.89 TDP1 (0.54) XDHTDP1KMT2AMEN1CYP3A4
SCHEMBL23488268 0.86 SMN1; SMN2 (0.55) XDHTDP1KMT2AMEN1CYP3A4
SCHEMBL12886328 0.84 ALDH1A1 (0.50) TDP1ALDH1A1SELPTYMPNPC1
SCHEMBL23488431 0.84 TDP1 (0.43) XDHTDP1ALDH1A1MAPTSELP
SCHEMBL23488119 0.84 XDH (0.49) XDHTDP1KMT2AALDH1A1SELP
SCHEMBL23488284 0.84 XDH (0.49) XDHTDP1KMT2AALDH1A1SELP
SCHEMBL23488272 0.84 TDP1 (0.43) XDHTDP1ALDH1A1MAPTSELP
SCHEMBL23488280 0.84 MAPT (0.48) XDHTDP1KMT2AMEN1L3MBTL1
SCHEMBL23488436 0.84 KMT2A (0.49) XDHTDP1KMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 XDH 3028/4885TDP1 4093/4885KMT2A 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.